Member Info for R00st3R

Also just to add that i am aware that i am barking up the wrong tree, when complaining or commenting here. I also know that whilst may investment may be bigger than that of Barclays, it may be dwarfed by that of HSBC.

Balderton Capital III,LP 6,813,196shares 9.19%

Blind Trust (Richard Sharp) 4,891,444shares 6.60%

Credit Suisse 4,326,454shares 5.84%

BNP Paribas Arbitrage 3,850,408shares 5.19%

Chelverton Asset Management 4,000,000shares 5.40%

Dr Adam M Hill 3,689,734shares 4.81%

Genostics Company Ltd 3,335,659shares 4.50%

Mr Timothy Brian Bunting 4,856,717shares 6.55%

Hargreaves Lansdown Asset Management 2,717,717shares 3.67%

HSBC Holdings Plc 2,539,848shares 3.43%

state of affairs....

Yea I know... itll take time... i just wished id know how to best spend the time as what i have given to ONC has been consumed without return of value, instead with return of significant worry and insecurity.

My nightmare would be if they'd turned around and said they just decided it was not worth the husstle and they sold the business - silently working out a deal in the background. It would be upset about the years gone by and the missed opportunity

My hope on the flip side is that they are sitting around a table and working out a simple plan to go from here to the moon. The rocket (ImmunoInsights platform) is there, we already had a few launches with mixed results. Neil Armstrong (A. Hill) and Buzz Aldrin (M. Hall) are now both not there anymore, + they never really landed on the moon to begin with..... and ONC have a fearless team that has hopefully been made just as motivated and excited about pushing through this mess through company share options.

Let's do this Martin and team. Its a straight line and it should be just straight forward. ONC should be a money pit. We should be at full capacity, not knowing how to fulfil all the orders. Occasionally ONC should be throwing up large sums of hard stinking cash..and leave that for us to feed on....

Looking forward to a Paul Hill / Martin Gouldstone interview in the near term. Might be further down the line to allow Martin to get a real grip on the business. We are all eagerly awaiting something :) I am also slightly nervous. When you have been kicked in the teeth as often as I have with ONC and other shares, you grow weary of any financial report when you have a steak ^^

I was not going to jump to the conclusion that they are fake but it sure looks like it.

Pumping money only to bring down my average. 35p would be a nice little milestone and still a road and journey ahead. The next investments need to be planned thoroughly and executed with distinction. The company needs to demonstrate that they can stabilise their expenses and grow revenue. Hiring a bunch of new executives surely won't be cheap for the business either.

Interesting chat. A few people trying to create the avalanche...

But only 1 trade and SP down. ^^ ... well I am not an expert but somethings seems off

I am a fool for hoping to make a profit, in a marketpleace with 3 other people

It's a long and drawn out affair. How the days, the weeks, months, yes even the years have gone by. And still I remain loyal to ONC. For all I can tell,

Now I wish I had been more patient.this drop looks like a nice buying price again

20k sold is 10% down. All I can say is that this seems a bit steep.

Possibly the same effect (or reversed for that matter) for when shares are bought?!

I think that now a first CEO introduction , statement and update is due. Let's hope they didn't forget about us ^^

The early cancer detection market is vast and also busy. I feel like ONC was not badly positioned but didn't have the leverage on its own. The multi year contract with Freenome is a good enough deal. I am secretly hoping that the long pause in commercial updates just means they are all heads down in work rather than sand.

Agreed. This is an upper from now. And honestly it can drop only 22 pence. But there is no limit to how high it can go. It was already at 12x its current price when their finances were a mich bigger mess than they would appear in the next report. Let's see what this new board is made of. Got to give them at least 1 fiscal year. So let's start the clock from......now

Topped up to see if I can trigger an avalanche. Anyway - news should be round the corner

Hey Dr. P.

No idea. We have two more weeks to the end of the quarter and year. I would imagine a TU to be around the corner to indicate generic updates ahead of the Annual report which I could imagine will be available sometime end of September, early October. But I don't think anyone really knows. I am seeing some more traction in the overall Biotech / Biopharma space. With earnings season in full swing and continuous focus on new drug development and vaccines etc. I like most of us are probably itching for some news.

Either way, the hurdles are out of the way. Let us see how the business seeks to maximise operational efficiency, sales and balance with lab capacity. At this point is feel like the numbers need to do the talking

Honestly it is a combination of thing in my view.

o Salaries coming in

o New CEO joining in matter of days

o Fed Reserve meetings yesterday and today

-pot. last 1-2 rate hikes ahead

o Q2 earnings season

o Upcoming end of financial year for ONC (Aug 31st)

-balance sheet will 100% be better than last

o Investors reshuffling portfolios now

o director buys

Etc.

But who knows what is really driving the trades. If it is director buys we should get RNS soon on that.

It depends. In some cases a new CEO means that change is on the horizon. New strategy, goals, reorganisation, and drive to improve top and bottom line and bring innovation etc.. depending on where the business is at in the given time. I feel like ONC has gone through the reorg and strategy definition already so my expectation would be the new CEO to bring business contacts, drives innovation (AI) and looks at scalable growth to improve the top line (first priority) - increase revenue. The company has been through rough seas over the last years. I think they need to build out the sales teams and partner networks and then focus at capacity to provide the services at scale i.e. new lab facility. Although given our current revenue it looks like the current facility in Dortmund should have plenty of unused capacity for right now.

Bad news is good to let out when the sp is already down imho so that then when momentum builds there won't be any more surprises (hopefully).

@Trek, it was wishful thinking. I didn't check the chart tbh. You are most likely right that our next stop is at 30 the 40 etc. 50 would be a big leap from here. I think that the new CEO joining next week will give a little confidence boost and hopefully a TU soon as well. Seem to just remember a lengthy linger around 50s....

@Dr. P. - 100% even if I had more to give right now. Nothing is guaranteed and I cannot pump more into this stock. I gave it a 5k boost too a few weeks back at what seemed to be rock bottom. My average is now decent enough for me to most likely break even if the business was acquired today.... still a ways to go on regular course though.

Missed the boat there Dr. ;) jk.... SP is still super attractive. I can imagine too that we will be heading toward 50p in a matter of just a few days

I wonder if they will wait for the full year end results to be published. Alistair noted in a recent report that FY23 was a challenging year. I think we can all piece together why but I wonder if the next report will be disappointing and he was preparing us for that. Macroeconomic headwinds seem to persist. In any case come October I think the we will be in the know and have clear direction from new BoD ahead and probably some skin in the game as it were.

I was just saying that if there was anything else, now would be a good time to air the laundry

No I think its all looking positive going forwards. Just a bit more patience. We have good things to look forward to

Not so fast Dr. P. - let's give them until 01 Aug. Seems like a good idea to throw out the trash news whilst the shares are in no man's land anyway.

Does anyone at this point have knowledge of what the expected IMMUNOInsights revenue for the full year is predicted to be?